Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Miller

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2018
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experienceBanu Atalar, Mahmut Ozsahin, Jason Call, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4Robert C Miller, David J Schwartz, Jeff A Sloan, et al.
JAMA|April 17, 2019
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical TrialTerence T Sio, Jennifer G Le-Rademacher, James L Leenstra, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2020
Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM)Mark R Waddle, William C Stross, Laura A Vallow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2006
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network studyEnis Ozyar, Ugur Selek, Siddihartha Laskar, et al.
Radiation Oncology (London, England)|September 7, 2018
Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature reviewJackson M May, Mark R Waddle, Daniel H Miller, et al.
Gynecologic Oncology|December 22, 2007
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)Hadassah Goldberg, Robert C Miller, Roxolyana Abdah-Bortnyak, et al.
Annals of Surgical Oncology|July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional ExperienceJingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Radiation Oncology (London, England)|September 29, 2011
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyAmol K Narang, Robert C Miller, Charles C Hsu, et al.
The Lancet. Oncology|August 5, 2006
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer NetworkAurelius Omlin, Maurizio Amichetti, David Azria, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2018
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experienceBanu Atalar, Mahmut Ozsahin, Jason Call, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4Robert C Miller, David J Schwartz, Jeff A Sloan, et al.
JAMA|April 17, 2019
Effect of Doxepin Mouthwash or Diphenhydramine-Lidocaine-Antacid Mouthwash vs Placebo on Radiotherapy-Related Oral Mucositis Pain: The Alliance A221304 Randomized Clinical TrialTerence T Sio, Jennifer G Le-Rademacher, James L Leenstra, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2020
Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM)Mark R Waddle, William C Stross, Laura A Vallow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2006
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network studyEnis Ozyar, Ugur Selek, Siddihartha Laskar, et al.
Radiation Oncology (London, England)|September 7, 2018
Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature reviewJackson M May, Mark R Waddle, Daniel H Miller, et al.
Gynecologic Oncology|December 22, 2007
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)Hadassah Goldberg, Robert C Miller, Roxolyana Abdah-Bortnyak, et al.
Annals of Surgical Oncology|July 31, 2015
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional ExperienceJingya Wang, Amol K Narang, Elizabeth A Sugar, et al.
Radiation Oncology (London, England)|September 29, 2011
Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative studyAmol K Narang, Robert C Miller, Charles C Hsu, et al.
The Lancet. Oncology|August 5, 2006
Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer NetworkAurelius Omlin, Maurizio Amichetti, David Azria, et al.
Pageof 17